Revolut is pushing SME banking in Australia with merchant acquiring at 0.5% and business accounts, but won't say how many AEs they're hiring or what the comp looks like. The company has 1 million local users and claims A$250 million in fee savings, but sales team details remain opaque.
The Sydney fintech postponed its ASX listing, citing Middle East war volatility. Directors opted for a private raise tha...
Funding & StartupsAdelaide mining tech startup DryFlow Magnetics is raising more capital on the same terms as its December seed round, led...
Anthropic reached $30 billion annualised revenue with roughly 5,000 employees, generating 6 to 10 times more revenue per head than Google did at the same scale. The AI company grew 30x in 15 months with no dedicated sales team, no CRO, and a research-heavy structure. OpenAI is running similar numbers: $24B revenue, 4,500 staff, doubling headcount to 8,000 by year end.
Every vendor deploying AI sales agents faces the same problem: not enough Forward Deployed Engineers to make the tech actually work inside customer environments. Traditional CS teams cannot fill the gap, and the agents cannot deploy themselves. Here is what that means for sales organisations hiring in 2026.
Australia's $335B sovereign wealth fund is reviewing 10 investment and ops roles after deploying new data systems. Expected savings: $10-15M in FY26/27, or 5-7% of costs. CEO Raphael Arndt says tech investment since COVID is now 'baked in.' This mirrors Bendigo Bank's recent AI-driven cuts and signals broader government sector automation.
## The Round Caruso, an Auckland-founded fund administration platform, closed a $9.3M Series A led by Icehouse Ventures and GD1. Post-money valuation: $80M. Balmain, a private credit fund manager and Caruso customer, participated. This follows a $3M seed round in December 2024. ## What They Do Caruso sells AI-powered fund admin software to real estate, private credit, and private equity funds. The platform handles investor onboarding, compliance (AML/KYC), capital raising, distributions, and registry management. Current customer base: 80+ fund managers (including Centuria Capital Group and Balmain), 900 funds, 27,000+ investors. Assets under administration sit at $80-100B. Revenue up 400% in the past year (no absolute figures disclosed). ## The Hiring Push Headcount is expanding from roughly 25 to 80+ across Auckland (HQ), Sydney, and Dallas. Australian headcount will double from current levels to around 40. No specific sales roles announced. No CRO or VP Sales named publicly. Co-founders Mark Hurley (CEO) and Oliver Shaw are the listed executives. For sales professionals eyeing fintech: this is early-stage, high-growth fund admin software. If you have experience selling to fund managers or private markets, this could be worth tracking. Comp details not disclosed. ## Market Context Fund administration is a legacy-heavy space. Most platforms are clunky, manual, and fragmented. Caruso is positioning as the AI-native alternative, targeting ANZ first with APAC and North America expansion planned. Competitors in this space include Carta (equity management with fund admin features), Capdesk (equity-focused), and traditional fund admin software providers. Caruso differentiates on AI integration and serving private credit/real estate funds specifically. ## Why It Matters Series A capital typically means structured hiring plans are coming. If you are in software sales and looking at fintech, fund admin is a niche with strong margins and sticky customers. Keep an eye on Caruso's careers page over the next quarter. For now: funding secured, headcount doubling, no public sales roles yet. Worth watching if you have experience selling to financial services or fund managers.
## The Exit Eucalyptus sold to US-based Hims & Hers for up to US$1.15 billion (A$1.6 billion). CEO Tim Doyle holds an estimated 10% stake, worth around US$160 million. The company hit 775,000 customers and US$450 million ARR run-rate by 2025. Four male founders. Zero women. Growth driven largely by GLP-1 weight-loss prescriptions to women. ## The Numbers That Matter In Australia, obesity rates sit at 31% for men, 32% for women. Clinical need is roughly equal. But women are 1.7x more likely to use GLP-1s in the US market, and Australian GP data shows women drive non-diabetic weight-loss prescriptions. Eucalyptus raised $50 million at A$520 million valuation in 2023. That valuation tripled via acquisition. Meanwhile, female founders in health tech report raising seed rounds at a fraction of that scale. ## The Pattern Catherine Slogrove, founder of women's microbiome health startup Amelia Bio, pointed out the disconnect. When Flo (period tracking app, all-male founding team) hit unicorn status, the backlash was immediate. Eucalyptus gets applause. Both built products primarily for women. Both had no women founders. Different reception. ## Why It Matters for Sales Teams If you are selling into health tech, enterprise buyers are starting to ask about founding team composition. DEI is moving from HR checkbox to procurement criteria. Companies building for women without women in leadership face tougher questions in enterprise deals. For sales professionals eyeing health tech roles: check who is on the founding team and who holds equity. Comp might look similar across companies, but long-term equity value depends on sustainable market positioning. Cultural pressure-driven growth has limits. ## The Comp Side No public data on Eucalyptus sales team size or CRO. The company scaled via marketing-led growth (founders came from ad agencies and Koala furniture). ARR over $450 million suggests a sizable team, now expanding under Hims & Hers. Doyle transitions to Senior Vice President of International post-acquisition. Co-founder Charlie Gearside departed early 2025. Equity distribution across the founding team remains undisclosed beyond Doyle's estimated 10%. ## Bottom Line Strong exit. Real numbers. Worth celebrating. Also worth asking why male founders building for female customers raise easier, exit bigger, and face less scrutiny than their female counterparts in the same market.
## The Numbers Eucalyptus sold to Hims & Hers for up to $1.6B. Four male co-founders. Zero women. The platform's growth engine: Juniper, targeting women seeking GLP-1 weight loss treatments. Women use these medications 1.7x more than men (15% vs 9% in the US). Australian obesity rates are nearly identical: 31% men, 32% women. The clinical need is equal. The demand is not. ## The Pattern This is the Flo playbook. Male founding team. Female customer base. Period tracking, weight loss, fertility: women's health built by men attracts capital. Women building for women struggle to raise. The data backs this up. Female founders receive roughly 2% of VC funding globally. In health tech, the gap widens. Investors fund solutions to problems they understand. Most VCs are men. ## Why This Matters for Go-to-Market Eucalyptus reached $450M ARR and 775,000 customers before the exit. The product worked. The team executed. The market was there. But representation shapes product, which shapes retention, which shapes revenue. Cultural pressure drives women to GLP-1s at higher rates than clinical need would predict. A founding team that lived that pressure might have built differently. The comp also matters. Co-founder Tim Doyle held 10% equity, worth roughly $160M from the deal. He becomes SVP International at Hims & Hers post-acquisition. Co-founder Charlie Gearside departed early 2025, pre-announcement. ## The Question Should founding team composition matter when the primary customer is a specific demographic? The ecosystem celebrated this exit without asking. When Flo hit unicorn status with zero female founders, the criticism was immediate. Eucalyptus shipped numbers. Triple-digit YoY ARR growth in 2025. The market validated the approach. But the funding gap persists: women building for women face higher scrutiny, lower valuations, longer fundraising cycles. Worth noting: Eucalyptus was not yet profitable. After-tax loss of $15.2M in FY2024. The $1.6B valuation is structured as $240M at close, $910M in deferred payments and earnouts through early 2029. Performance-based. The real payout depends on hitting targets. ## What Sales Teams Should Watch Telehealth is scaling fast. Eucalyptus went from founding in 2019 to $450M ARR in six years. That is enterprise software velocity in a healthcare wrapper. The buyer was Hims & Hers, a US public company expanding into ANZ. Watch for hiring. International expansion usually means local sales teams, territory planning, and market education. Doyle's SVP role suggests aggressive ANZ growth plans. For anyone selling into health tech or building GTM for women's health products: the money is there. The customers are there. The representation gap remains.
Pay.com.au has shelved its planned ASX IPO and raised $20 million privately instead, blaming geopolitical uncertainty from the Iran war for spooking public market sentiment. The business was eyeing an $850 million valuation on the ASX this month. The private raise valued it at $750 million, according to a company spokesperson. That is a $100 million haircut for choosing private capital over public markets. In a term sheet to investors, directors said an immediate IPO is "not in the best interests of shareholders" given current macro conditions. The business will keep watching for ASX listing opportunities, but no timeline provided. ## What this means for sales teams IPO delays usually mean hiring freezes or slower expansion. Pay.com.au has not disclosed sales headcount, recent hires, or whether the pivot changes their go-to-market plans. Worth noting: the business won Smart50 in 2024 and was reportedly planning to raise $85 million pre-IPO before the market turned. The fintech operates in B2B payments, founded by Damien Waller, Edward Alder, and Grant Austin. No public data on sales team size, CRO, or enterprise versus SMB split. ## Broader fintech context Pay.com.au joins a long list of fintechs postponing IPOs in 2025. Stripe and Klarna have both pushed back public market plans. SoftBank's PayPay and Walmart-backed PhonePe delayed roadshows citing similar geopolitical shocks. ANZ fintech has seen hiring freezes and comp cuts across the sector in 2024-2025, particularly for SDR and AE roles. When IPO plans get shelved, expansion hiring usually follows. Whether Pay.com.au is pausing sales hiring alongside the IPO delay remains unclear. The spokesperson said the business is in a "strong financial position" and choosing private capital "preserves momentum without the constraints of public market timing." Translation: they can still grow, but probably slower than an $850 million float would have funded.
## The Numbers Anthropic hit $30 billion annualized revenue in Q1 2026 with an estimated 5,000 employees. That is $6 million revenue per employee. Google needed 32,000 people to reach $30B. Salesforce needed 79,000. The revenue ramp: - End of 2024: $1B ARR - Mid 2025: $4B - End of 2025: $9B - March 2026: $30B That is 30x growth in 15 months. Investor Brad Gerstner noted Anthropic added the equivalent of Databricks plus Palantir combined in revenue in a single month. ## What This Means for Sales Teams No public data on Anthropic's sales org structure. No named CRO or VP Sales in available records. The company runs research-heavy with teams focused on Interpretability, Alignment, and Societal Impacts. Product leadership saw Tom Krieger move to Anthropic Labs in January 2026, replaced by Ami Vora. OpenAI sits at $24B revenue with 4,500 employees, planning to double headcount to 8,000 by end of 2026. Still far leaner than traditional enterprise software. Comp data: Not publicly available for Anthropic sales roles. No confirmed ANZ presence or operations. Activity centers in San Francisco. ## The Efficiency Model Anthropic's lean structure comes from focus. No multimodal sprawl, no hardware, no data centers. They picked coding and enterprise, went deep. Compute costs are relatively fixed whether revenue is $1B or $80B, so gross margins expand as revenue scales. Inference costs down 90% year over year. ## What Changes If AI companies can hit $30B with 5,000 people, enterprise software sales models shift. Traditional SaaS companies scaled headcount with revenue. Salesforce added thousands of AEs, SEs, CSMs to reach $30B. That model does not apply when your primary cost input is compute, not people. For sales professionals: Fewer seats, higher productivity expectations, different comp structures. When a company can generate $6M per employee instead of $380k (Salesforce's ratio at $30B), quota and OTE calculations change. Worth noting: Anthropic's efficiency comes from product-led motion and enterprise co-work focus, not traditional outbound sales teams. The playbook does not translate directly to most B2B companies. But the direction is clear: leaner teams, AI-assisted workflows, higher revenue per head. No data yet on how this affects quota attainment, ramp periods, or territory design for the sales roles that do exist.
## The Bottleneck No One Saw Coming Every company rolling out AI agents at scale is running into the same problem: forward deployed engineers are impossible to hire. The shortage is not just a hiring challenge. It is a structural issue about what it actually takes to get AI working inside a real enterprise. FDEs sit at the intersection of product, engineering, and customer success. They go on-site, understand actual workflows, and configure the product to work inside those workflows. They are not building from scratch. They are not doing basic support. They are doing the hard middle work of making software actually land in the real world. Palantir built their entire go-to-market around this model. You needed their people inside your organisation, configuring and training the system for your specific context. That model worked. It was expensive and it did not scale the way SaaS was supposed to scale. But it worked, because complex software in complex environments requires human judgement to deploy well. Now almost every serious AI product has the same requirement. And almost no one has enough people who can do it. ## Why CS Cannot Fill This Gap The instinct at most companies: solve this with customer success. CS is already post-sale, already focused on adoption. Just upskill them, right? Wrong. Traditional CS was built for a different era. The job was: help customers use software they have already decided to buy, make sure they hit their renewal metrics, escalate bugs. It was reactive, relationship-driven, and optimised for retention. FDE work is different in almost every way. It is proactive, technical, and optimised for deployment. You are going in before the problem exists and configuring the system so the problem never happens. The skill set required is closer to a solutions engineer or a junior product manager with strong customer empathy than it is to a traditional CS rep. Most CS teams do not have it. Retraining takes longer than most companies want to admit. ## Agents Cannot Deploy Themselves. Yet. The whole premise of AI agents is that they automate work. But deploying an AI agent is itself significant work, and it is work the agent cannot do for you. Not yet. Someone has to understand the customer's workflows deeply enough to know where the agent fits. Someone has to train the agent on the right data, the right context, the right edge cases. Someone has to test it, catch where it breaks, and iterate. Someone has to get internal buy-in from the people whose jobs will change when the agent goes live. That is FDE work. And it is manual, high-judgement, human work. Palantir announced recently that they have gotten deployment times down over 90% using forward deployed engineers. That is remarkable. It also means the best-in-class operator in this model is still deploying manually, just faster. 90% reduction in deployment time is not the same as automating deployment. The human is still in the loop. ## What This Means for Sales Teams Every serious AI vendor is now competing for the same small pool of people who can do this work. The companies that came up through Palantir, the solutions engineers from the major cloud platforms, the implementation consultants from the enterprise software world: everyone wants them, and there are not enough of them. Meanwhile the demand is exploding. Every enterprise that decides to deploy AI agents needs FDE-calibre people to make it work. For sales teams, this creates a few realities: **Longer sales cycles.** If you cannot deploy the product, you cannot prove value. If you cannot prove value, the deal stalls. **Higher implementation costs.** Companies are paying premium rates for FDEs. That cost gets passed somewhere, usually to the customer or to margin. **New comp structures.** Some vendors are tying commission to successful deployment, not just closed deals. If the product does not land, the rep does not get paid out fully. The companies winning at deployment are building serious enablement programmes: not just documentation, but hands-on training that gives customer-side operators the skills to configure and train agents themselves. If you are selling AI tools, ask your leadership what the deployment plan actually looks like. If the answer is "CS will handle it," the answer is wrong.
The same legal scrutiny that just cost Woolworths and Optus billions is coming for your comp plan—and most ANZ sales orgs are not ready.
Microsoft's hiring freeze isn't a surprise—it's the inevitable end of tech's decade-long talent hoarding mistake.
When the poster child of Australian tech blames AI for cutting 10% of staff, it's not about the technology—it's about finally admitting they overhired during the free money years.